Transgenomic s Q4 Revenues Soar on Sales of DNA Analysis Product | GenomeWeb

NEW YORK, Jan 31 – Based on increased sales of its genomic mutation analysis tools, Omaha, Neb.-based Transgenomic reported increased revenues for the fourth quarter Wednesday, while losses decreased and expenses held steady.

The company reported fourth quarter revenues of $7.1 million, up 63 percent from revenues of $4.3 million in the third quarter of 1999.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.